Sage Journals: Discover world-class research

Open access

Research article

First published 2018

Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab

John Syrios, Evelina Pappa, Nikolaos Volakakis [...]

Breast Cancer: Basic and Clinical Research

Open access

Brief report

First published 2026

Updated cost comparison of home care subcutaneous versus outpatient intravenous trastuzumab for HER2-positive breast cancer in Singapore

Yanting Ouyang, Yi Ting Ng, Wei Wei Hong [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2025-4

Evaluation of cost and infusion-related reactions among intravenous trastuzumab,subcutaneous trastuzumab,and trastuzumab biosimilars at an academic medical center

Daijah M Davis, Kasey Jackson, Christina Hoppe

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2019-9

Subcutaneous auto-administration of trastuzumab following therapeutic education: A case report

Marine Deppenweiler, Marc Debled, Jean-Luc Robquin [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2020-8

Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients

Jonathan González García, Fernando Gutiérrez Nicolás, Ruth Ramos Díaz [...]

Annals of Pharmacotherapy

Retricted access

Review article

First published 2021-7

Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive breast cancer: A multidisciplinary approach

Barbara DuMond, Vidhi Patel, Anne Gross [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2024

Cost-minimization analysis comparing subcutaneous trastuzumab at home with intravenous trastuzumab for HER2-positive breast cancer in Singapore

Yanting Ouyang, Han Yi Lee, Fun Loon Leong [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2020-3

Trastuzumab/Hyaluronidase-oysk: A New Option for Patients With HER2-Positive Breast Cancer

Marissa R. Duco, Joshua L. Murdock, David J. Reeves

Annals of Pharmacotherapy

Open access

Brief report

First published 2024-04

An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer

Dionisia Quiroga, Robert Wesolowski, Sara Zelinskas [...]

Cancer Control

Retricted access

Research article

First published 2024-6

Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis

Marliese Alexander, Kim Jachno, Kelly-Anne Phillips [...]

Journal of Oncology Pharmacy Practice

Search results